Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population-Reference-Cited by-同舟云学术

Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population

Published:2020-04-06 Issue:6 Volume:76 Page:807-814
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Mandal Tatiyana^ORCID,Bairy Laxminarayana Kurady,Sharma Podila Satya Venkata Narasimha

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-020-02866-4.pdf

Reference45 articles.

1. Preskorn SH (1997) Clinically relevant pharmacology of selective serotonin reuptake inhibitors. Clin Pharmacokinet 32:1–21

2. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826

3. Sánchez C, Bøgesó KP, Ebert B et al (2004) Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology 174:163–176

4. Steimer W (2010) Pharmacogenetics and psychoactive drug therapy: ready for the patient? Ther Drug Monit 32:381–386

5. Malhotra AK, Lencz T, Correll CU, Kane JM (2007) Genomics and the future of pharmacotherapy in psychiatry. Int Rev Psychiatry 19:523–530

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Sequence Variations Affecting Serotonin Transporter Transcriptional Regulation and Activity: Do They Impact Alcohol Addiction?;International Journal of Molecular Sciences;2024-07-25

2. Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers;International Journal of Neuropsychopharmacology;2023-01-19

3. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder;Human Psychopharmacology: Clinical and Experimental;2022-01-06

4. Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2021-03-31

5. No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients;Clinical Neuropharmacology;2021-01-21